<?xml version="1.0" encoding="UTF-8"?>
<ref id="b22-1040138">
 <label>22.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hermine</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Hoster</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Walewski</surname>
    <given-names>J</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL younger): a randomised, open-label phase 3 trial of the European Mantle Cell Lymphoma Network</article-title>. 
  <source>Lancet</source>. 
  <year>2016</year>;
  <volume>388</volume>(
  <issue>10044</issue>):
  <fpage>565</fpage>â€“
  <lpage>575</lpage>.
  <pub-id pub-id-type="pmid">27313086</pub-id>
 </mixed-citation>
</ref>
